Na Gai's most recent trade in TherapeuticsMD Inc was a trade of 8,500 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2025 | 8,500 | 8,500 | - | - | Restricted Stock Units | |
| Calisa Acquisition Corp | Na Gai | Director, Chairwoman of the Board, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Oct 2025 | 201,000 | 1,468,975 | - | 0 | Ordinary Shares | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 8,500 | 8,500 | - | - | Restricted Stock Unit | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 07 Dec 2022 | 3,922 | 0 (0%) | 0% | 5.3 | 20,635 | Common Stock |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 3,922 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 96,864 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units |